Senior insider sale
EVP, Chief Technical Ops. Off. at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$2.51M
5.27K shares
What this filing means
ATKINSON EDWARD MORROW III plans to sell 5.27K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $2.51M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/25/2026ACC: 0001959173-26-001467
Officer· EVP, Chief Technical Ops. Off.
Since Feb 2026
5.27K
Shares to sell
$2.51M
Approx. market value
668.00
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/24/2026
668.00Total acquired668.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/24/2026 | Restricted Stock Vesting Compensation | 668.00 | — |
| Total | 668.00 | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
817.00
Market value
$387.0K
2/18/2026
—Completed
Units to sell
2.03K
Market value
$994.1K
2/17/2026
—Completed
Units to sell
1.75K
Market value
$806.2K
2/11/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
668.00
Market value
$324.9K
2/25/2026
Total
Units
5.27K
Value
$2.51M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/18/2026 | 817.00 | $387.0K | — | Completed |
2/17/2026 | 2.03K | $994.1K | — | Completed |
2/11/2026 | 1.75K | $806.2K | — | Completed |
| Planned — Approximate Date | ||||
2/25/2026 | 668.00 | $324.9K | NASDAQ | Planned |
| Total | 5.27K | $2.51M | ||